231 related articles for article (PubMed ID: 14562286)
21. Cellular and molecular biology of biliary tract cancers.
Rashid A
Surg Oncol Clin N Am; 2002 Oct; 11(4):995-1009. PubMed ID: 12607585
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas.
Min Kim S; Sun CD; Park KC; Kim HG; Lee WJ; Choi SH
J Surg Oncol; 2006 Oct; 94(5):418-25. PubMed ID: 16967453
[TBL] [Abstract][Full Text] [Related]
23. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.
Petmitr S; Pinlaor S; Thousungnoen A; Karalak A; Migasena P
Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):71-5. PubMed ID: 9740272
[TBL] [Abstract][Full Text] [Related]
24. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
25. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
[TBL] [Abstract][Full Text] [Related]
26. Genetic alterations and growth pattern in biliary duct carcinomas: loss of heterozygosity at chromosome 5q bears a close relation with polypoid growth.
Hidaka E; Yanagisawa A; Seki M; Setoguchi T; Kato Y
Gut; 2001 May; 48(5):656-9. PubMed ID: 11302964
[TBL] [Abstract][Full Text] [Related]
27. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
Basturk O; Chung SM; Hruban RH; Adsay NV; Askan G; Iacobuzio-Donahue C; Balci S; Zee SY; Memis B; Shia J; Klimstra DS
Virchows Arch; 2016 Nov; 469(5):523-532. PubMed ID: 27591765
[TBL] [Abstract][Full Text] [Related]
28. Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas.
Maru D; Wu TT; Canada A; Houlihan PS; Hamilton SR; Rashid A
Oncogene; 2004 Jan; 23(3):859-64. PubMed ID: 14647445
[TBL] [Abstract][Full Text] [Related]
29. Cholangiocarcinoma with intraductal tubular growth pattern versus intraductal papillary growth pattern.
Tsukahara T; Shimoyama Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nakamura S; Nagino M
Mod Pathol; 2016 Mar; 29(3):293-301. PubMed ID: 26769137
[TBL] [Abstract][Full Text] [Related]
30. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.
Abraham SC; Reynolds C; Lee JH; Montgomery EA; Baisden BL; Krasinskas AM; Wu TT
Hum Pathol; 2002 Jan; 33(1):39-46. PubMed ID: 11823972
[TBL] [Abstract][Full Text] [Related]
31. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
Goeppert B; Stichel D; Toth R; Fritzsche S; Loeffler MA; Schlitter AM; Neumann O; Assenov Y; Vogel MN; Mehrabi A; Hoffmann K; Köhler B; Springfeld C; Weichenhan D; Plass C; Esposito I; Schirmacher P; von Deimling A; Roessler S
Gut; 2022 Feb; 71(2):391-401. PubMed ID: 33468537
[TBL] [Abstract][Full Text] [Related]
33. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
Schoedel KE; Finkelstein SD; Ohori NP
Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481
[TBL] [Abstract][Full Text] [Related]
34. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model.
Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B
Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086
[TBL] [Abstract][Full Text] [Related]
35. Oncocytic papillary neoplasms of the biliary tract: a clinicopathological, mucin core and Wnt pathway protein analysis of four cases.
Rouzbahman M; Serra S; Adsay NV; Bejarano PA; Nakanuma Y; Chetty R
Pathology; 2007 Aug; 39(4):413-8. PubMed ID: 17676483
[TBL] [Abstract][Full Text] [Related]
36. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G
Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
[TBL] [Abstract][Full Text] [Related]
37. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
38. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
39. Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver.
Tannapfel A; Benicke M; Katalinic A; Uhlmann D; Köckerling F; Hauss J; Wittekind C
Gut; 2000 Nov; 47(5):721-7. PubMed ID: 11034592
[TBL] [Abstract][Full Text] [Related]
40. Biliary intraductal tubule-forming neoplasm: a whole exome sequencing study of MUC5AC-positive and -negative cases.
Akita M; Hong SM; Sung YN; Kim MJ; Ajiki T; Fukumoto T; Itoh T; Zen Y
Histopathology; 2020 Jun; 76(7):1005-1012. PubMed ID: 32181510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]